14 December 2020 in Proceedings of the National Academy of Sciences
Significance: Age-related bioenergetic insufficiency increases the vulnerability of retinal ganglion cells to intraocular pressure during glaucoma pathogenesis. This paper addresses these relationships and provides a deeper understanding of this common neurodegeneration. We demonstrate an intraocular pressure-dependent decline in retinal pyruvate levels coupled to dysregulated glucose metabolism, and detected mTOR activation at the mechanistic nexus of neurodegeneration and metabolism. Supporting this, oral supplementation of pyruvate or mTOR inhibition by rapamycin strongly protects from neurodegeneration. Bioenergetic enhancement thus provides a readily clinically translatable strategy for neurodegenerative disease. This study provides important avenues for neuroprotection against glaucoma by targeting key metabolic pathways that may be mirrored in other neurodegenerative diseases in which metabolic dysregulation may play a key role.
1 October 2018 in Cell Stem Cell
1 January 2014 in Gene Expression Patterns
5 July 2014 in Current Ophthalmology Reports
1 May 2016 in Seminars in Cell & Developmental Biology
12 November 2021 in Science Advances
FGF and Wnt signaling controls the phase transition of the ocular fate.